Alkyl Amines Chemicals Limited AI Stock Analysis
Want to see IN:ALKYLAMINE full AI Analyst Report?
Alkyl Amines Chemicals Limited (ALKYLAMINE) AI Stock Analysis
Alkyl Amines Chemicals Limited
(NSE:ALKYLAMINE)
The score is primarily supported by strong financial resilience (very low leverage and generally positive cash generation). Technicals are moderately constructive with price above key moving averages, but weakened momentum (negative MACD) tempers the outlook. The biggest drag is valuation, with a high P/E and low dividend yield requiring stronger earnings momentum to justify the price.
Alkyl Amines Chemicals Limited (ALKYLAMINE) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 82.97B
- Dividend Yield
- 0.62%
- Average Volume (3M)
- 6,551
- Price to Earnings (P/E)
- 33.2
- Beta (1Y)
- 0.89
- Revenue Growth
- 13.38%
- EPS Growth
- 35.82%
- Country
- India
- Employees
- 692
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Alkyl Amines Chemicals Limited Business Overview & Revenue Model
Company Description
Alkyl Amines Chemicals Limited functions as a global producer and purveyor of a diverse portfolio of chemical substances, encompassing various amines, their derivatives, and a selection of specialized chemicals. The company's offerings include alipha...
Alkyl Amines Chemicals Limited Financial Statement Overview
Summary
Overall fundamentals are supported by an exceptionally conservative balance sheet (minimal debt, strong flexibility) and generally positive operating cash generation. Offsetting this, profitability and returns have cooled from the 2021–2023 peak, gross margins have compressed, and revenue growth has become inconsistent (including declines in 2024 and 2026), indicating softer momentum versus the prior cycle.
Income Statement
63PositiveBalance Sheet
92Very PositiveCash Flow
70Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.15B | 15.36B | 15.72B | 14.41B | 16.83B | 15.42B |
| Gross Profit | 3.83B | 5.35B | 7.14B | 6.54B | 8.04B | 6.92B |
| EBITDA | 2.22B | 3.16B | 2.98B | 2.55B | 3.49B | 3.27B |
| Net Income | 1.40B | 1.80B | 1.86B | 1.49B | 2.29B | 2.25B |
Balance Sheet | ||||||
| Total Assets | 0 | 18.95B | 17.89B | 15.84B | 15.90B | 13.71B |
| Cash, Cash Equivalents and Short-Term Investments | 2.51B | 2.51B | 2.03B | 303.92M | 171.95M | 615.33M |
| Total Debt | 0 | 11.90M | 55.20M | 31.68M | 877.50M | 232.89M |
| Total Liabilities | -15.33B | 3.62B | 3.86B | 3.16B | 4.21B | 3.82B |
| Stockholders Equity | 15.33B | 15.33B | 14.02B | 12.67B | 11.69B | 9.90B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 1.10B | 2.15B | 1.53B | -550.40M | -422.81M |
| Operating Cash Flow | 0 | 2.39B | 2.63B | 2.75B | 2.48B | 2.05B |
| Investing Cash Flow | 0 | -1.37B | -1.96B | -1.21B | -2.77B | -2.06B |
| Financing Cash Flow | 0 | -560.90M | -491.50M | -1.40B | 80.00M | -572.89M |
Alkyl Amines Chemicals Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ALKYLAMINE, the sentiment is Negative. The current price of 1614.30 is below the 20-day moving average (MA) of 1695.53, below the 50-day MA of 1813.24, and below the 200-day MA of 1685.38, indicating a bearish trend. The MACD of -65.52 indicates Positive momentum. The RSI at 40.43 is Neutral, neither overbought nor oversold. The STOCH value of 22.77 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ALKYLAMINE.
Alkyl Amines Chemicals Limited Peers Comparison
Overall Rating
IN:VINATIORGA70Outperform
IN:ALKYLAMINE69Neutral
IN:BALAMINES56Neutral
IN:AARTIIND47Neutral
IN:JUBLINGREA46Neutral
IN:LXCHEM46Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 70Outperform | INR 110.31B | 27.83 | ― | 0.77% | 10.98% | -5.48% | |
| 69Neutral | INR 82.84B | 33.18 | ― | 0.62% | 13.38% | 35.82% | |
| 56Neutral | INR 58.20B | 24.85 | ― | 0.61% | 20.91% | 62.44% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 47Neutral | INR 166.59B | 29.54 | ― | 0.21% | 39.85% | 103.71% | |
| 46Neutral | INR 93.41B | 26.99 | ― | 0.83% | 15.41% | 21.76% | |
| 46Neutral | INR 45.19B | 26.66 | ― | 0.18% | 21.34% | 105.39% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:ALKYLAMINE | Alkyl Amines Chemicals Limited | 1614.30 | -153.23 | -8.67% | |
| IN:AARTIIND | AARTI Industries Ltd | 484.30 | 91.73 | 23.37% | |
| IN:BALAMINES | Balaji Amines Limited | 1822.45 | 568.41 | 45.33% | |
| IN:JUBLINGREA | Jubilant Ingrevia Ltd. | 599.10 | -77.25 | -11.42% | |
| IN:LXCHEM | Laxmi Organic Industries Ltd. | 165.15 | -23.03 | -12.24% | |
| IN:VINATIORGA | Vinati Organics Limited | 1105.50 | -540.34 | -32.83% |
Alkyl Amines Chemicals Limited Corporate Events
Alkyl Amines shareholders clear board restructuring and leadership extensions
Alkyl Amines Chemicals Limited has secured shareholder approval via postal ballot and remote e-voting for a suite of special resolutions that reshape its senior leadership structure. Key changes include the re-designation of Yogesh M. Kothari as Exec...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 07, 2026
